GlaxoSmithKline

About:

GlaxoSmithKline develops and markets products in the areas of pain relief, respiratory, digestive health, oral health, nutrition and skin.

Website: http://www.gsk.com

Twitter/X: gsk

Top Investors: CARB-X

Description:

GlaxoSmithKline is a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer. The company aims to bring differentiated, high-quality and needed healthcare products to as many people as possible, with its 3 global businesses, scientific and technical know-how, and talented people. GSK's Pharmaceuticals business has a broad portfolio of innovative and established medicines with commercial leadership in respiratory and HIV. Our R&D approach focuses on science related to the immune system, the use of genetics, and advanced technologies. The Vaccines business has a broad portfolio and innovative pipeline of vaccines to help protect people throughout life. It delivers over two million vaccine doses per day to people living in over 160 countries. The Consumer Healthcare business develops and markets an innovative portfolio of consumer preferred and expert-recommended brands in the Pain relief, Respiratory, Digestive health, Oral Health, Nutrition, and Skin health categories.

Total Funding Amount:

$25.5M

Estimated Revenue Range:

$10B+

Headquarters Location:

London, England, United Kingdom

Founded Date:

1929-01-01

Contact Email:

Simon.M.Bicknell(AT)gsk.com

Founders:

John Smith, Nicholas Babaian

Number of Employees:

10001+

Last Funding Date:

2021-03-02

IPO Status:

Public

Industries:

© 2025 bioDAO.ai